Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea · Delayed Price · Currency is KRW 2,260.00
+145.00 (6.86%)
At close: Jul 27, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 183.31 billion as of July 28, 2026. Its market cap has increased by 134.09% in one year.
Market Cap
183.31B
Enterprise Value
160.11B
Revenue
3.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,260.00
ChartMarket Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 183.31B, an increase of 41.74%. That is a compound annual growth rate of 3.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 183.31B | -15.99% |
| Dec 30, 2025 | 218.21B | 92.71% |
| Dec 30, 2024 | 113.23B | -15.48% |
| Dec 28, 2023 | 133.97B | 21.98% |
| Dec 29, 2022 | 109.83B | -11.47% |
| Dec 30, 2021 | 124.06B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IntoCell | 291.43B |
| HansBiomed | 272.39B |
| IMBiologics | 261.44B |
| S.Biomedics | 214.39B |
| curacle co.,ltd. | 184.07B |
| Genome & Company | 171.97B |
| Kanaph Therapeutics | 165.89B |
| Bio Solution | 164.63B |